Arkolith/Insider Trading/ATHA/Form 4

Worthington Mark

General Counsel and CCOAthira Pharma, Inc. (ATHA) · full profile →Form 4 · filed Jul 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2025Sell(S)9K$0.29$2K112K
Jun 30, 2025Option exercise(M)37K—$0120K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2025Option exercise(M)37K—$037K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-019066) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Athira Pharma, Inc.

Build

Ask your agent about ATHA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-25-019066"
Ask your agent
Use Arkolith to summarize insider buying and selling at Athira Pharma, Inc.
over the last 90 days and cite the filings.